Refine
Year of publication
Has Fulltext
- yes (1224)
Is part of the Bibliography
- no (1224)
Keywords
- Heavy Ion Experiments (21)
- Hadron-Hadron scattering (experiments) (12)
- Hadron-Hadron Scattering (11)
- LHC (9)
- Heavy-ion collision (6)
- Heavy-ion collisions (5)
- Seizure (5)
- ALICE experiment (4)
- Collective Flow (4)
- Jets (4)
- Quark-Gluon Plasma (4)
- ALICE (3)
- Diffraction (3)
- Epilepsy (3)
- Heavy Ions (3)
- Heavy Quark Production (3)
- Jets and Jet Substructure (3)
- pp collisions (3)
- Beam Energy Scan (2)
- Beauty production (2)
- Charm physics (2)
- Chiral Magnetic Effect (2)
- Collectivity (2)
- Corona (2)
- Correlation (2)
- Costs (2)
- Elastic scattering (2)
- Elliptic flow (2)
- Epileptischer Anfall (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Genetics (2)
- Germany (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Pandemic (2)
- Pandemie (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- QCD (2)
- Quarkonium (2)
- SARS-CoV‑2 (2)
- Shear viscosity (2)
- Single electrons (2)
- Status epilepticus (2)
- classical Hodgkin lymphoma (2)
- epilepsy (2)
- immunotherapy (2)
- 900 GeV (1)
- ALICE detector (1)
- Angiomyolipoma (1)
- Anti-nuclei (1)
- Anti-seizure medication (1)
- Anticonvulsant (1)
- B-cell transcription factors (1)
- B-slope (1)
- Bacteriophages (1)
- Beam energy scan (1)
- Beskid Niski Mts (1)
- Biophysical chemistry (1)
- Boosted Jets (1)
- Brain tumor (1)
- COVID-19 (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charged-particle multiplicity (1)
- Charm quark spatial diffusion coefficient (1)
- Chiral magnetic effect (1)
- Coalescence (1)
- Cold nuclear matter effects (1)
- Collective Flow, (1)
- Comparison with QCD (1)
- Covid19-nmr (1)
- Critical point (1)
- DNA methylation (1)
- Data sharing (1)
- Depression (1)
- Deuteron production (1)
- Di-hadron correlations (1)
- EWSR1 (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Ethiopia (1)
- Everolimus (1)
- FGFR (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- Forward physics (1)
- Gene fusion (1)
- Groomed jet radius (1)
- HBT (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hard Scattering (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-Ion Collision (1)
- Heavy-flavor decay electron (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Higher moments (1)
- Immunogenetics (1)
- Immunology (1)
- Inclusive spectra (1)
- Intensity interferometry (1)
- Interference fragmentation function (1)
- Invariant Mass Distribution (1)
- Ionisation energy loss (1)
- J/ψ suppression (1)
- Jet Physics (1)
- Jet Substructure (1)
- Jet substructure (1)
- Lafora disease (1)
- MN1 (1)
- MTOR inhibitor (1)
- Material budget (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Monte Carlo (1)
- Multi-Parton Interactions (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Multiple parton interactions (1)
- NF-κB (1)
- NMR spectroscopy (1)
- Neural network (1)
- Neuroepithelial (1)
- Neurooncology (1)
- Nuclear modification factor (1)
- PATZ1 (1)
- PD-L1 (1)
- PYTHIA (1)
- Particle and Resonance Production (1)
- Pb–Pb (1)
- Pediatric (1)
- Production Cross Section (1)
- Properties of Hadrons (1)
- Proton-proton collisions (1)
- Proton–proton (1)
- Proton–proton collisions (1)
- Psychiatric disorders (1)
- Quality of life (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- RHIC (1)
- RNA (1)
- Rapidity Range (1)
- Relativistic heavy ion physics (1)
- Relativistic heavy-ion collisions (1)
- Resolution Parameter (1)
- Rhabdomyoma (1)
- SARS-CoV-2 (1)
- STAR (1)
- Single muons (1)
- Sociodemographic characteristics (1)
- SoftDrop (1)
- Splitting function (1)
- Subependymal giant cell astrocytoma (1)
- Systematic Uncertainty (1)
- TR (1)
- TSC (1)
- Thermal model (1)
- Tigray (1)
- Time Projection Chamber (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Transversity (1)
- Trigger (1)
- Vector Boson Production (1)
- Xenon-based gas mixture (1)
- aftercare structures (1)
- alteplase (1)
- anticonvulsants (1)
- brain metastases (1)
- cHL (1)
- cerebral pseudoprogression (1)
- chronic kidney disease (1)
- cluttering (1)
- complication (1)
- dE/dx (1)
- detector (1)
- diabetic nephropathy (1)
- endovascular thrombectomy (1)
- epidemiology (1)
- epigenetic (1)
- epileptic encephalopathies (1)
- experimental results (1)
- fibroblasts (1)
- fragment screening (1)
- gene expression analysis (1)
- genetics (1)
- global change (1)
- habitat destruction (1)
- healthcare systems (1)
- heavy ion experiments (1)
- heavy-ion collisions (1)
- high-fat-diet (1)
- honey bee classification (1)
- immune checkpoint inhibitor (ICI) (1)
- immune checkpoint inhibitors (ICI) (1)
- immune related adverse events (irAE) (1)
- immunohistochemistry (1)
- infection (1)
- inpatient hospital admissions (1)
- juvenile myoclonic epilepsy (1)
- land use (1)
- leptin receptor-deficient mouse (1)
- levetiracetam (1)
- lichen diversity (1)
- lichenized fungi (1)
- liver (1)
- liver transplantation (1)
- liver transplantation center (1)
- lockdown (1)
- long-term outcome (1)
- loss of B-cell phenotype (1)
- lungs (1)
- luteolin (1)
- mTOR inhibitor (1)
- mechanical recanalization (1)
- medical informatics initiative (1)
- metabolomics (1)
- methylation profiling (1)
- miRNA (1)
- microRNA (1)
- microdissection (1)
- mir-148a (1)
- morbidity (1)
- mtDNA haplotypes (1)
- myxomycete (1)
- neurocritical care (1)
- neurological complication (1)
- neurological side effects (1)
- new records (1)
- nodular sclerosis (1)
- p+p collisions (1)
- pandemic (1)
- pharmacoresistance (1)
- post-liver transplantation management (1)
- prediabetes and type 2 diabetes (1)
- progressive myoclonus epilepsy (1)
- quark gluon plasma (1)
- rare species (1)
- reduced kidney function (1)
- saprotrophic fungi (1)
- secondary data analysis (1)
- seizure (1)
- spectra (1)
- stuttering (1)
- thrombolysis (1)
- tyrosine kinase inhibitor (TKI) (1)
- university hospitals (1)
- wing geometric morphometrics (1)
- Υ suppression (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1085)
- Frankfurt Institute for Advanced Studies (FIAS) (1056)
- Informatik (924)
- Medizin (30)
- Biodiversität und Klima Forschungszentrum (BiK-F) (3)
- Biowissenschaften (3)
- Geowissenschaften / Geographie (3)
- Informatik und Mathematik (3)
- Hochschulrechenzentrum (2)
- Institut für Ökologie, Evolution und Diversität (2)
The article Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life‑Sustaining Therapies: A Systematic Review, written by Laurent M. Willems, Sebastian Bauer, Kolja Jahnke, Martin Voss, Felix Rosenow, Adam Strzelczyk, was originally published Online First without Open Access. After publication in volume 34, issue 8, pages 801–826 the author decided to opt for Open Choice and to make the article an Open Access publication. Post-publication open access was funded by Projekt DEAL. Therefore, the copyright of the article has been changed to © The Author(s) 2021 and the article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. The original article has been corrected.
Introduction: Dravet syndrome (DS) is a rare developmental and epileptic encephalopathy. This study estimated cost, cost-driving factors and quality of life (QoL) in patients with Dravet syndrome and their caregivers in a prospective, multicenter study in Germany.
Methods: A validated 3–12-month retrospective questionnaire and a prospective 3-month diary assessing clinical characteristics, QoL, and direct, indirect and out-of-pocket (OOP) costs were administered to caregivers of patients with DS throughout Germany.
Results: Caregivers of 93 patients (mean age 10.1 years, ±7.1, range 15 months–33.7 years) submitted questionnaires and 77 prospective diaries. The majority of patients (95%) experienced at least one seizure during the previous 12 months and 77% a status epilepticus (SE) at least once in their lives. Over 70% of patients had behavioural problems and delayed speech development and over 80% attention deficit symptoms and disturbance of motor skills and movement coordination. Patient QoL was lower than in the general population and 45% of caregivers had some form of depressive symptoms. Direct health care costs per three months were a mean of €6,043 ± €5,825 (median €4054, CI €4935-€7350) per patient. Inpatient costs formed the single most important cost category (28%, €1,702 ± €4,315), followed by care grade benefits (19%, €1,130 ± €805), anti-epileptic drug (AED) costs (15%, €892 ± €1,017) and ancillary treatments (9%, €559 ± €503). Total indirect costs were €4,399 ±€ 4,989 (median €0, CI €3466-€5551) in mothers and €391 ± €1,352 (median €0, CI €195-€841) in fathers. In univariate analysis seizure frequency, experience of SE, nursing care level and severe additional symptoms were found to be associated with total direct healthcare costs. Severe additional symptoms was the single independently significant explanatory factor in a multivariate analysis.
Conclusions: This study over a period up to 15 months revealed substantial direct and indirect healthcare costs of DS in Germany and highlights the relatively low patient and caregiver QoL compared with the general population.
The Board of Directors of the German Society of Epileptology and the committee on epilepsy and syncope of the German Society of Neurology have reviewed the current data on vaccination to prevent coronavirus disease 2019 (COVID-19) and vaccination prioritization in people with epilepsy and provide a summary and recommendations.
Purpose: Seizures pose a significant burden in patients with primary and secondary brain tumors during the end-of-life period. A wide range of 6 to 56% of clinically observed epileptic seizures at the end of life has been reported. We aimed to analyse the incidence of epileptic seizures at the end of life in brain tumor patients more accurately using not only clinical but also electrophysiological findings.
Methods: This retrospective, single center study included brain tumor patients who died during the stay on the ward or within 7 days after discharge between 01/2015 and 08/2020. Clinical observation of seizures derived from the original medical records and EEG findings (within 45 days prior to death) were analyzed to determine the incidence of seizures in that period.
Results: Of the 68 eligible patients, 50 patients (73.5%) suffered from seizures within 45 days prior to death, of which n = 24 had a status epilepticus. The diagnosis of seizures/ status epilepticus was determined either by the presentation of clinical signs in 45 patients and if not, by the detection of a (possible) non-convulsive status epilepticus in the EEG of five patients.
Conclusion: In the presence of neurologically trained staff and with the frequent use of routine EEG, we were able to identify seizures and to distinguish status epilepticus from encephalopathy/ hypoactive delirium. We detected a higher incidence of seizures and status epilepticus at the end of life in neurooncological patients than previously reported.